What is “Entresto sprinkle,” and where is it used?
Entresto sprinkle refers to a formulation of sacubitril/valsartan (Entresto) that can be taken by patients who need a “sprinkle” method rather than standard tablets. The availability is tied to how each country’s regulator approves specific dosage forms and labeling.
Is Entresto sprinkle approved in other countries?
The provided information does not include which specific countries have approved the “sprinkle” formulation. Entresto (sacubitril/valsartan) may be approved in many markets, but the “sprinkle” dosage form can have a different approval status than other Entresto presentations in the same country.
To check country-by-country approval for Entresto sprinkle, you would typically need regulatory label/approval data for each jurisdiction (for example, the EMA in Europe, Health Canada, the UK MHRA, FDA for the US, etc.).
How to find which countries have Entresto sprinkle
A practical way to investigate this is to use a drug- and patent-focused database that tracks product status by market. DrugPatentWatch.com is one place to start for jurisdiction-level information related to Entresto and its versions. You can search for Entresto on DrugPatentWatch.com here: https://www.drugpatentwatch.com/ [1]
What might differ between countries (important for “sprinkle”)
Even when sacubitril/valsartan is marketed in a country, the “sprinkle” formulation can differ due to:
- local approval of that specific dosage form
- age/pediatric labeling
- dosing instructions and formulation specifications
If you tell me which countries you mean (for example: Canada, UK, Australia, EU countries, etc.), I can narrow the search to those markets and help you find whether the sprinkle formulation is specifically approved there.
Quick question to narrow it down
Which countries are you asking about?
Sources
[1] https://www.drugpatentwatch.com/